AuditCompensationNominating and Corporate GovernanceScientific
John C. Martin, PhD 
John C. Martin, PhD
Executive Chairman


Dr. Martin joined Gilead Sciences in 1990 and was appointed Executive Chairman in March 2016. He served as Chairman and Chief Executive Officer from June 2008 through March 2016 and President and Chief Executive Officer from 1996 through May 2008. Prior to joining Gilead, Dr. Martin held several leadership positions at Bristol-Myers Squibb and Syntex Corporation. Dr. Martin previously served as President of the International Society for Antiviral Research, Chairman of the Board of Directors ... 

    
Jacqueline K. Barton, PhD 
Jacqueline K. Barton, PhD
Profressor, California Institute of Technology


Dr. Barton is the John G. Kirkwood and Arthur A. Noyes Professor of Chemistry and Norman Davidson Leadership Chair of the Division of Chemistry and Chemical Engineering at the California Institute of Technology, where she has been a member of the faculty for nearly 30 years. She has served on the Board of Directors of the Dow Chemical Company from 1993-2017 and is currently a member of the Material Sciences Advisory Committee of DowDupont, Inc. She founded and served on the Board of GeneOhm Scie... 
    Committee Member
John F. Cogan, PhD  Lead Director
John F. Cogan, PhD
Lead Independent Director, Gilead Sciences


John F. Cogan, PhD joined Gilead’s Board of Directors in July 2005 and was appointed Lead Independent Director in May 2013. Dr. Cogan is currently the Leonard and Shirley Ely Senior Fellow at the Hoover Institution at Stanford University. Dr. Cogan’s current research is focused on U.S. budget and fiscal policy, health care and social security. Dr. Cogan has held a number of positions in the U.S. government, including Assistant Secretary for Policy in the U.S. Department of Labor and Associate... 

Committee Member    Committee Member
Kelly A. Kramer Financial Expert
Kelly A. Kramer
Executive Vice President and Chief Financial Officer, Cisco Systems, Inc.


Kelly A. Kramer joined Gilead’s Board of Directors in August 2016. Ms. Kramer is currently Executive Vice President and Chief Financial Officer of Cisco Systems, Inc. She previously served as Vice President and Chief Financial Officer of GE Healthcare Systems and Chief Financial Officer of GE Healthcare Biosciences. Ms. Kramer has also worked in GE’s Corporate Headquarters, Transportation Systems and Aerospace divisions. She is a member of the board of the Silicon Valley Chapter of City Year,... 

Committee Member    
Kevin E. Lofton, FACHE 
Kevin E. Lofton, FACHE
Chief Executive Officer, Catholic Health Initiatives


Kevin E. Lofton joined Gilead’s Board in July 2009. He is currently the Chief Executive Officer of Catholic Health Initiatives. Headquartered in Denver, the healthcare system has revenues of over $15 billion and operates the full continuum of services from hospitals to home health agencies throughout the nation. He previously served as Chief Executive Officer of two university hospitals, the UAB Hospital and Howard University Hospital. In 2007, Mr. Lofton served as Chairman of the Board of th... 

Committee Member Committee Member   
John F. Milligan, PhD 
Biography PhotoJohn F. Milligan, PhD
President and Chief Executive Officer, Gilead Sciences


Dr. Milligan joined Gilead Sciences in 1990 and was appointed Chief Executive Officer in March 2016. He was appointed President in 2008, and from 2007 to 2016 served in the role of Chief Operating Officer as well. He previously held multiple leadership roles within Gilead, including the position of Chief Financial Officer from 2002 to 2007.

Dr. Milligan was named "Bay Area CFO of the Year" in 2006 for companies with revenues greater than $500 million, and he was named the top biotec... 
    
Nicholas G. Moore Financial Expert
Nicholas G. Moore
Retired Global Chairman, PricewaterhouseCoopers


Nicholas G. Moore joined Gilead’s Board of Directors in March 2004. Mr. Moore is the retired global Chairman of PricewaterhouseCoopers LLP, a professional services firm formed in July 1998 by the merger of Coopers & Lybrand and Price Waterhouse. Prior to the merger, Mr. Moore was elected Chairman and Chief Executive Officer of Coopers & Lybrand (U.S.) in 1994 and Coopers & Lybrand International in 1997. Mr. Moore is a director of Bechtel Group, Inc. and previously served as lead independent d... 

Chairperson Committee Member   
Richard J. Whitley, MD 
Richard J. Whitley, MD
Distinguished Professor, Loeb Scholar Chair in Pediatrics, Professor of Pediatrics, Microbiology, Medicine, and Neurosurgery, University of Alabama at Birmingham


Dr. Whitley joined Gilead's Board of Directors in 2008. He is a Distinguished Professor, Loeb Scholar Chair in Pediatrics, and Professor of Microbiology, Medicine and Neurosurgery at the University of Alabama at Birmingham. He is the Co-Director, Division of Pediatric Infectious Diseases; Vice-Chair, Department of Pediatrics; Senior Scientist, Department of Gene Therapy; Director for Drug Discovery and Development and Senior Leader, Comprehensive Cancer Center; Associate Director for Clinical... 

   Committee Member Chairperson
Gayle Edlund Wilson 
Gayle Edlund Wilson
Chairman Emeritus of COSMOS, The California State Summer School for Math and Science


Gayle Edlund Wilson joined Gilead’s Board of Directors in October 2001. Mrs. Wilson served as California’s First Lady from 1991 to 1999. Mrs. Wilson is a member of the board of directors of the Ralph M. Parsons Foundation, a non-profit organization that provides grants for higher education, social impact, civic, cultural issues and health issues. She is also the Chair Emeritus of the Advisory Board of the California State Summer School for Math and Science, and a member of the board of truste... 

   Chairperson Committee Member
Per Wold-Olsen 
Per Wold-Olsen
Retired President,
Human Health Intercontinental Division, Merck & Co., Inc.


Mr. Wold-Olsen joined Gilead’s Board of Directors in January 2010 after serving as the Chair of the company’s Health Policy Advisory Board since 2007. From 2005 to 2006, Mr. Wold-Olsen served as President of the Human Health Intercontinental Division of Merck & Co., Inc., a leading global pharmaceutical company. From 1997 until 2005, he served as President of Human Health Europe, Middle East/Africa and Worldwide Human Health Marketing for Merck & Co.,Inc. Mr. Wold-Olsen is currently Chairman ... 

  Chairperson Committee Member Committee Member
  • Member
  • Chairperson
  • Financial Expert

   Mr. Cogan is the Lead Independent Director.